基本資料
種類: ETF
費用比率%: 0.44
資產淨值: 3,297.58
成立日期: 05/02/2001
 
分析
市值分佈:
87.84%
大市值
8.15%
中市值
2.60%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 11/07/2026 05:59) 總持有投資項目: 240  
0%
 
100%
     10大 (44.69%)
代號 名稱 佔比% 持有日期
VRTXVertex Pharmaceuticals8.0730/06/2026
AMGNAmgen7.8230/06/2026
GILDGilead Sciences6.8330/06/2026
REGNRegeneron Pharmaceuticals4.9030/06/2026
SGEN--4.1630/11/2023
ARGXargenx SE3.7530/06/2026
ALNYAlnylam Pharmaceuticals3.1230/06/2026
NTRANatera2.8930/06/2026
RVMDRevolution Medicines2.7830/06/2026
BIIBBiogen2.4630/06/2026
ILMNIllumina2.0730/06/2026
MRNAModerna1.9830/06/2026
INSMInsmed Incorporated1.7830/06/2026
ONCBeOne Medicines Ltd1.7730/06/2026
INCYIncyte Corp1.7530/06/2026
UTHRUnited Therapeutics Corp1.7330/06/2026
ROIVRoivant Sciences Ltd1.4230/06/2026
NBIXNeurocrine Biosciences1.3030/06/2026
ASNDAscendis Pharma A/S1.2930/06/2026
GMABGenmab A/S ADS1.1230/06/2026
 1    2    3    4    5    6    7    8    9    10    11    12  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.